Guillain-Barré syndrome following COVID-19: new infection, old complication?

WHO (2020) Coronavirus disease 2019 (COVID-19). https://www.who.int/emergencies/diseases/novel-coronavirus-2019

Zhou F, Yu T, Du R et al (2020) Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 395(10229):1054–1062

Mao L, Wang M, Chen S, et al. (2020) Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. MedRxiv 2020:2020.02.22.20026500.

Willison HJ, Jacobs BC, van Doorn PA (2016) Guillain-Barré syndrome. Lancet 388:717727

Uncini A, Kuwabara S (2018) The electrodiagnosis of Guillain-Barré syndrome subtypes: where do we stand? Clin Neurophysiol 129:2586–2593

Zhao H, Shen D, Zhou H, et al (2020) Guillain-Barré syndrome associated with SARS CoV-2 infection: causality or coincidence? Lancet Neurol.

Xie X, Zhong Z, Zhao W et al (2020) Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology 26:200642. https://doi.org/10.1148/radiol.2020200343

Okar SV, Bekircan-Kurt CE, Hacıoğlu S et al (2020) Toscana virus associated with Guillain-Barré syndrome: a case-control study. Acta Neurol Belg. https://doi.org/10.1007/s13760-020-01279-5

Wanleenuwat P, Iwanowski P, Kozubski W (2020) Antiganglioside antibodies in neurological diseases. J Neurol Sci 408:116576

Wakerley BR, Yuki N (2015) Mimics and chameleons in Guillain-Barré and Miller Fisher syndromes. Pract Neurol 15(2):90–99

Kim JE, Heo JH, Kim HO et al (2010) Neurological complications during treatment of Middle East respiratory syndrome. J Clin Neurol 13(3):227–233